Tybost (cobicistat) is a small molecule pharmaceutical. Cobicistat was first approved as Tybost on 2013-09-19. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Stribild's patents are valid until 2032-10-06 (FDA).
|Drug Class||Enzyme inhibitors|